Bipolar Depression: Symptoms, Diagnosis, and Course
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar depression is a depressive episode occurring in the course of bipolar disorder. It can change mood, energy, sleep, appetite, concentration, physical activity, relationships, and the ability to manage daily life. Some people experience depression for substantially more time than they experience mania or hypomania. The decisive clinical question is how a depressive episode fits into the person's lifetime pattern of mood episodes. Depression alone cannot establish bipolar I disorder or bipolar II disorder. The National Institute of Mental Health (NIMH) and the 2023 VA/DoD clinical guideline place the depressive presentation within a broader diagnostic assessment. For the complete condition overview, see Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment.
Many people initially seek help for exhaustion, inability to enjoy things, persistent sadness, or difficulty functioning. A prior period of hypomania may have felt productive or ordinary, so it may not appear in the first account of the problem. Accurate assessment brings past and present changes in mood, activity, sleep, functioning, and safety into a longitudinal clinical history. This article explains the clinical meaning of bipolar depression, the symptoms that warrant attention, the boundaries of diagnosis, the course of the illness, and the evidence guiding care.
For additional clinical context, see Mania vs Hypomania: Key Differences in Symptoms and Impairment.
What Is Bipolar Depression?
Bipolar depression is a term for the depressive phase of a bipolar illness, generally referring to a major depressive episode occurring in someone with bipolar I or bipolar II disorder. The episode can resemble major depressive disorder in someone who has never experienced mania or hypomania. Its bipolar context becomes apparent from the history of elevated or unusually irritable mood accompanied by a sustained increase in energy or activity, the severity and duration of those periods, and other clinical information. The VA/DoD guideline explicitly cautions that an individual depressive episode cannot reliably distinguish bipolar depression from unipolar major depression.
Bipolar I disorder requires a history of at least one manic episode; a major depressive episode is frequent but not required for that diagnosis. Bipolar II disorder requires at least one hypomanic episode and at least one major depressive episode, without any history of full mania. Cyclothymic disorder involves recurrent hypomanic and depressive symptoms that do not reach the complete thresholds for the respective episodes. These distinctions appear in the NIMH classification and the World Health Organization's ICD-11 clinical descriptions. A focused account of the manic-defined condition appears in Bipolar I Disorder: Symptoms, Diagnosis, and Treatment.
The term bipolar does not imply hourly alternation between happiness and sadness. Episodes can persist for weeks or months, and people can experience substantial intervals of stability or lingering symptoms that fall below full episode criteria. Sadness after a loss, temporary fatigue, a day of irritability, or an occasional surge of enthusiasm cannot establish a bipolar disorder. Diagnosis concerns defined episodes, changes from baseline, functional consequences, and alternative explanations.
Symptoms of Bipolar Depression
Depressed mood and loss of pleasure
A depressive episode may involve sustained sadness, emotional emptiness, despair, hopelessness, or a loss of the capacity to feel pleasure. Some people describe numbness more readily than sadness. Formerly enjoyable activities may feel meaningless, and social connection may demand unusual effort. Irritability can accompany the depressive state, particularly when ordinary demands become overwhelming. Worthlessness, excessive guilt, pessimistic thinking, and feelings of failure may intensify the experience. These depressive features are described by NIMH.
The assessment asks how these experiences differ from the person's usual life. Enjoying solitude is an ordinary preference; withdrawing because nothing feels worthwhile and daily functioning has declined is a potentially important clinical change. A clinician also considers stress, bereavement, medical conditions, and other possible explanations. No one emotional quality uniquely identifies bipolar depression.
Fatigue, activity, and psychomotor change
Low energy can be profound. Routine tasks such as cooking, showering, replying to messages, or traveling to work may require sustained effort. Some people speak and move more slowly than usual, while others become agitated, pace, or feel unable to settle. Psychomotor slowing and agitation are different possible expressions of depression. The NIMH depressive symptom framework includes both physical slowing and restlessness.
Functional impairment helps establish severity. A person may continue attending work or school yet struggle to maintain concentration, complete assignments, provide care for dependents, or protect their health. Visible productivity does not rule out serious depression, and the need for help should be assessed against the person's actual demands and safety rather than outward appearance.
Sleep and appetite
Sleep may become shorter, fragmented, or difficult to initiate, with early waking and a feeling of exhaustion. Other people sleep unusually long hours but remain tired. Appetite and weight may decrease or increase. These changes can have medical and behavioral explanations, so they are examined in context. In particular, insomnia during depression is clinically different from the reduced need for sleep that can accompany mania or hypomania, when a person may sleep much less and still feel unusually energized. NIMH distinguishes depressive sleep changes from elevated-mood sleep patterns. The sleep-focused discussion is in Bipolar Disorder and Sleep.
A record of sleep duration, bedtime, waking time, and daytime energy can help identify clinically meaningful changes. Tracking is useful when it clarifies the history and supports treatment decisions. A few poor nights of sleep, however, do not establish a mood episode, and a wearable device or sleep diary cannot diagnose bipolar disorder.
Concentration, memory, and decision-making
Depression can make reading, planning, conversation, and decision-making unusually difficult. People may reread the same page, forget appointments, lose their train of thought, or experience overwhelming doubt about simple choices. Repetitive self-criticism may further undermine attention. Because anxiety, sleep disorders, ADHD, medication effects, and medical conditions can also affect cognition, the timing and episodic nature of cognitive symptoms are important. The NICE assessment recommendations call for attention to coexisting conditions.
Thoughts of death or self-harm
Some depressive episodes include thoughts that life is not worth living, wishes to disappear, thoughts of self-harm, or suicidal intent. These experiences warrant direct and compassionate assessment regardless of whether the person appears calm or remains outwardly productive. The NIMH overview identifies suicidal thoughts among depressive symptoms, and NICE emphasizes risk assessment and appropriate crisis care.
If a person may act on suicidal thoughts, has a suicide plan, cannot maintain immediate safety, or is severely disorganized or unable to care for basic needs, obtain urgent emergency assessment. Contact local emergency services or a local crisis service, and remain with the person when it is safe to do so. In the United States, call or text 988 for the Suicide & Crisis Lifeline. Recurring thoughts of death without immediate intent still deserve timely professional assessment.
How Long Must Symptoms Last to Count as an Episode?
A major depressive episode generally requires at least two weeks of depressed mood or markedly reduced interest or pleasure, accompanied by other qualifying symptoms. The symptoms occur much of the day on most days and produce clinically significant distress or impairment. Additional features can involve sleep, appetite, energy, concentration, movement, feelings of worthlessness, and thoughts of death. Clinicians consider whether a substance, medication, physical condition, or other explanation accounts for the symptoms. See the VA/DoD diagnostic guideline and NIMH.
Two weeks is a minimum episode threshold, not an expected recovery deadline or an instruction to delay seeking care. A depressive episode can persist much longer. Even symptoms that fall short of the complete criteria may be clinically significant when they cause distress or functional limitations. Assessment considers intensity, persistence, change from baseline, and the person's ability to manage daily responsibilities.
Severity depends on more than a symptom count. A clinician evaluates functional disruption, psychotic symptoms if present, suicide risk, capacity for self-care, and medical or social vulnerabilities. Treatment and monitoring needs vary accordingly. A brief online checklist cannot substitute for this broader evaluation.
Bipolar I Depression and Bipolar II Depression
Bipolar I depression occurs in the context of a disorder established by mania. During mania, changes in mood and energy may produce major impairment, hospitalization, or psychotic symptoms. A person with bipolar I may nevertheless spend long periods predominantly depressed. Bipolar II involves hypomania and major depression, without full mania. Hypomania is a distinct period of changed mood and increased energy or activity, typically less severe than mania; it does not include the marked impairment or psychosis that would make an episode manic. These distinctions are described by NIMH.
Bipolar II should not be characterized as a mild version of bipolar I. Its depressive burden can be considerable, including repeated episodes and prolonged functional impairment. The fact that someone has never experienced full mania offers no guarantee that their depression is slight. Prospective studies of bipolar I course and bipolar II course document significant depressive morbidity in both diagnostic groups, while showing important variation from one individual to another. The separate diagnosis and its depressive burden are explained in Bipolar II Disorder: Symptoms, Diagnosis, and Treatment.
Mixed Features and Psychotic Symptoms
Some people experience depression alongside symptoms normally associated with elevated mood or activation. These may include racing thoughts, increased energy, unusual talkativeness, distractibility, or reduced need for sleep. When formal clinical criteria are satisfied, clinicians may describe a depressive episode with mixed features. Mixed features are not established by irritability or anxiety alone, and several medical, substance-related, and psychiatric conditions can produce overlapping experiences. The NIMH account of mixed mood presentations and NICE risk and assessment recommendations support careful evaluation. For a dedicated assessment of this presentation, see Bipolar Disorder With Mixed Features.
One clinically useful distinction is between sleeping poorly while feeling exhausted and needing very little sleep while feeling energized and driven. The latter may signal hypomanic or manic activation. Likewise, restlessness during severe anxiety can look superficially similar to increased activity during a mood episode, but the circumstances, associated symptoms, and longitudinal pattern matter. Mixed features warrant particular attention when depression worsens in combination with agitation, impulsivity, or impaired judgment.
Severe depressive episodes sometimes involve psychotic symptoms, such as delusions or hallucinations. Psychosis requires prompt specialist assessment and may indicate that urgent care is needed, especially when safety, self-care, or reality testing is seriously affected. The clinician evaluates whether psychotic symptoms occur within mood episodes or suggest another condition. Psychosis alone does not prove bipolar disorder. NICE CG185 addresses the management of risk and severe presentations.
How Is Bipolar Depression Diagnosed?
The clinician reconstructs the lifetime mood history
Clinical evaluation documents the current depressive syndrome and then asks about past changes in mood and activity. Questions may explore prolonged periods of elation, unusual irritability, increased confidence, more goal-directed activity, fast speech, racing thoughts, decreased need for sleep, impulsive spending, risky behavior, unusual social behavior, and episodes resulting in hospitalization or marked disruption. The duration, severity, functional consequences, and relationship of these changes to substances or medications help differentiate mania, hypomania, and ordinary variations in mood. NICE guidance for suspected bipolar disorder emphasizes a detailed history, functioning, and corroborating information when appropriate. The full assessment pathway is developed in How Is Bipolar Disorder Diagnosed? Clinical Assessment Explained.
Past hypomania may be missed because it sometimes feels like a welcome escape from depression. A person may recall being especially energetic or productive without recognizing the experience as a distinct mood episode. Clinicians therefore ask about concrete behavior, sleep, and observations from others rather than relying on the question of whether the patient has ever felt manic. With consent, a relative or trusted person may help clarify changes the patient does not remember.
Comprehensive assessment and differential diagnosis
A thorough assessment covers previous episodes, family psychiatric history, severity and duration, the effect on work and relationships, current risk, psychotic or mixed features, physical health, prescribed and nonprescribed substances, and coexisting disorders. Depending on the history, medical examination or laboratory tests may be indicated to investigate thyroid or other medical conditions that can affect mood and energy. There is no blood test or brain scan that establishes bipolar depression. The VA/DoD guideline separates diagnosis and triage from treatment decisions.
Screening questionnaires can identify people who may benefit from further evaluation, but screening is a preliminary step. Positive results are not bipolar diagnoses, and negative results do not resolve compelling historical evidence. A definitive clinical formulation requires evaluation of episode criteria and differential explanations, sometimes across multiple appointments as longitudinal information emerges.
Preparing for an appointment
A short chronological record can improve the quality of the discussion: when depressive symptoms began, whether similar periods occurred previously, how sleep and energy changed, whether unusually active periods occurred, what observers noticed, which medications or substances were involved, and what the effects were on everyday life. It is also important to mention suicidal thoughts, possible psychotic experiences, and any history of markedly reduced need for sleep or impaired judgment. These details help a clinician evaluate the full course; they are not a self-diagnosis method. NICE recommends a comprehensive assessment and collaborative management planning.
Bipolar Depression vs Major Depressive Disorder
Depressive symptoms overlap substantially across bipolar illness and major depressive disorder. A person in either group may have profound fatigue, insomnia or hypersomnia, loss of pleasure, guilt, slowed thinking, and hopelessness. The most important diagnostic distinction concerns a credible history of mania or hypomania, evaluated alongside the person's broader course. The VA/DoD guideline warns against using depressive symptoms alone to identify bipolar illness.
Researchers have investigated whether early age at onset, repeated depressive episodes, family history, hypersomnia, psychotic depression, diurnal changes in mood, or particular symptom combinations are associated with a bipolar course. In a comparative study, Forty and colleagues (2008) identified several group-level differences between bipolar and unipolar depression. These features may prompt a more detailed interview, but they are not reliable stand-alone diagnostic tests. Someone who sleeps too much does not necessarily have bipolar disorder; someone without hypersomnia may still have it.
The distinction has treatment implications because evidence-based care for bipolar depression is not identical to care for unipolar depression. In particular, antidepressant monotherapy is generally not recommended in bipolar I depression, and treatment-emergent mood elevation or destabilization is an important consideration. CANMAT/ISBD (2023) and NICE CG185 address these phase-specific decisions. A separate article in the EN-02 architecture owns the complete bipolar-versus-major-depression comparison.
Other Conditions That Can Resemble Bipolar Depression
Anxiety disorders, trauma-related conditions, ADHD, borderline personality disorder, sleep disorders, substance-related disorders, and medical illnesses can involve changes in mood, energy, concentration, or sleep. Sometimes these conditions coexist with bipolar illness. ADHD symptoms tend to have a developmental and persistent course, whereas mania and hypomania involve distinguishable episodes of mood and activity change. Borderline personality disorder can involve emotional instability whose temporal pattern and interpersonal context differ from a classic mood episode, although real presentations may be complex. Clinical evaluation assesses each possibility without reducing it to a checklist. NICE CG185 calls for recognition and management of coexisting disorders.
Medication- or substance-associated mood changes require special care in interpretation. Stimulants, certain prescribed treatments, intoxication, withdrawal, and other influences may alter energy or behavior. The presence of depression after a medication change does not automatically establish a bipolar diagnosis, nor does an apparently activating response to an antidepressant settle the matter by itself. A timeline that integrates treatment exposure, symptom duration, and prior episodes supports a more reliable assessment.
Causes and Risk Factors
Bipolar disorder involves interacting genetic, biological, developmental, and environmental influences. Family history can be relevant to clinical suspicion, while individual risk cannot be determined from family history alone. Research explores sleep-wake regulation, circadian processes, stress responsiveness, and other neurobiological mechanisms, but no single pathway explains every depressive episode or supplies a clinical diagnostic biomarker. The NIMH overview describes the complex contribution of genetic and environmental factors.
Periods of major stress, disrupted sleep, physical illness, or other changes may precede episodes in some people. Such associations can help an individual recognize patterns, but a temporal trigger is not proof of causation. Episodes may also occur without an obvious precipitating event. Clinical discussion of potential triggers should improve practical prevention planning rather than encourage blame or unrealistic efforts to control every life event.
Duration and Long-Term Course
The minimum duration of a major depressive episode is two weeks, but individual episodes can last months. Some people improve substantially between episodes, while others retain residual depressive symptoms that continue to affect sleep, concentration, work, and relationships. Mood episodes may recur in different forms over the lifespan. Long-term understanding therefore requires attention to full episodes, subthreshold symptoms, and actual functioning. NIMH describes the episodic and potentially recurrent course.
In a prospective study of 146 patients with bipolar I disorder followed for a mean of 12.8 years, Judd and colleagues (2002) found mood symptoms present during 47.3% of follow-up weeks. Depressive symptoms occupied 31.9% of weeks, compared with 8.9% involving mania or hypomania and 5.9% involving cycling or mixed symptoms. These figures characterize one longitudinal research cohort, not the expected trajectory of every person with bipolar I disorder.
A separate study followed 86 people with bipolar II disorder for a mean of 13.4 years and documented a substantial burden of depressive symptoms over time. Judd and colleagues (2003) highlight the importance of depressive morbidity in bipolar II and the need to attend to symptoms even when full episode thresholds are not met. Historical samples, treatment settings, severity at enrollment, and observation methods restrict direct generalization of these data to all patients today.
Remission, recovery, and relapse
Remission means that symptoms have decreased sufficiently to meet an accepted clinical threshold. Recovery also concerns rebuilding functioning and returning to valued activities and roles. A person may regain interest before concentration or physical energy fully recovers. Similarly, a long interval without a major episode does not automatically eliminate the possibility of recurrence. Longer-term assessment tracks both symptoms and quality of life. NICE CG185 recommends care plans that include relapse recognition and ongoing monitoring.
Rapid cycling has a particular clinical definition involving four or more qualifying mood episodes within a year. It is not the same as several fluctuations in mood during one day. The nature of episodes, their separation in time, and the person's history are necessary for applying this term. NIMH discusses rapid cycling in its bipolar classification and symptom overview. The episode criteria and course are addressed in Rapid Cycling Bipolar Disorder.
Treatment and Clinical Care
Treatment planning starts with depressive severity, bipolar subtype, prior response, suicide risk, mixed or psychotic symptoms, physical health, coexisting conditions, current treatment, and patient preferences. Evidence for acute bipolar depression, acute mania, and maintenance treatment differs. An intervention that helps prevent manic recurrence may not have equivalent evidence for relieving a current depressive episode. The 2023 VA/DoD guideline separates acute bipolar depression from mania management, and the CANMAT/ISBD recommendations distinguish treatment phases and diagnostic subtypes. A broader treatment map appears in Bipolar Disorder Treatment: Medication, Therapy, and Long-Term Care.
Medications and essential safety monitoring
Guidelines include specific medications used in bipolar depression, potentially including quetiapine, lithium, lamotrigine, and other agents depending on bipolar subtype and the applicable evidence. Selection depends on previous response, clinical severity, adverse effects, drug interactions, medical history, access, and individual preferences. Recommendations for bipolar I and bipolar II do not fully overlap. Medication comparisons belong to a specialist treatment discussion, because effects in bipolar depression cannot be inferred simply from a drug's role in treating mania. Consult CANMAT/ISBD (2023), VA/DoD (2023), and NICE CG185.
Lithium requires monitoring of blood levels, kidney and thyroid function, and circumstances that can increase toxicity risk, including dehydration and some interactions. Lamotrigine carries a serious rash warning and requires careful titration. Some antipsychotic medications can cause metabolic, sedating, movement-related, or other adverse effects, making individualized physical-health monitoring important. Valproate has major reproductive and pregnancy-related risks and requires specialist prescribing safeguards. These concerns appear in the medication and monitoring sections of NICE CG185. Do not start, stop, or change medication dosing based on a general article; decisions must be made with the prescribing clinician.
Antidepressants deserve particular scrutiny. Antidepressant monotherapy is not recommended for bipolar I depression, and the possibility of mania, hypomania, or mood destabilization must be considered. The evidence and recommendations for selected bipolar II presentations are more nuanced, which further underscores the need for an accurate diagnosis and specialist supervision. People taking an antidepressant who develop markedly reduced sleep need, unusual activation, impulsivity, or other sudden changes should contact their treating clinician promptly. They should not abruptly discontinue a prescribed treatment without medical guidance. See the CANMAT/ISBD evidence update.
Psychotherapy and additional support
Structured psychological interventions can address depressive symptoms, strengthen coping, improve communication and daily routines, and support recognition of early warning signs. NICE guidance recommends bipolar-specific psychological interventions or appropriate evidence-based psychotherapy options for adults with bipolar depression. Therapy may be integrated with pharmacological care when indicated. Treatment should be adapted to the person's clinical situation rather than assuming every technique is equally effective for every illness phase.
A systematic review and component network meta-analysis of 39 randomized trials found evidence that adjunctive psychosocial treatments, including family, cognitive behavioral, and psychoeducational approaches, can improve certain longer-term bipolar outcomes. Trial populations, interventions, outcome measures, and the treatment phase vary, so relapse-prevention evidence does not by itself establish immediate antidepressant effectiveness. The relevant question is which intervention improves the particular outcome being targeted.
When urgent treatment is needed
Severe suicidal intent, psychosis, inability to maintain basic self-care, severe agitation, or a sudden manic escalation can require urgent emergency or specialist care. Some severe or high-risk episodes are managed in hospital. Electroconvulsive therapy may be considered in selected severe presentations through specialist assessment; it has particular indications, risks, and consent procedures. The NICE guideline and VA/DoD guideline provide clinical frameworks for evaluating severe episodes. Emergency safety takes priority over completing a diagnostic checklist.
Daily Life and Supporting Someone With Bipolar Depression
During depression, it may help to make essential tasks more manageable: establish realistic goals, preserve opportunities for sleep, arrange regular meals, continue agreed clinical appointments, and seek support for practical responsibilities. Appropriate workplace or educational accommodations can reduce avoidable pressure while functioning improves. These steps supplement rather than replace clinical treatment. NICE emphasizes recovery planning, patient preference, and collaboration.
A simple mood and sleep diary can assist in recognizing changes in energy, sleep need, depressive burden, and activation. Records should include what matters clinically without turning daily life into an exhausting monitoring exercise. Such information is best discussed with the treating professional, who can interpret the pattern in the context of medication, medical factors, and episode history.
Supportive relatives and friends may help with appointments, food, transport, childcare, or agreed daily routines. They can ask directly about safety when concerned and take seriously reports of suicidal thoughts or drastic changes in sleep and behavior. Involving a trusted person in a clinical plan, with consent where appropriate, can be helpful, but family members do not diagnose episodes or alter medication. The VA/DoD guideline and patient-family resources address collaborative care.
Children, Pregnancy, and Older Adults
In adolescents, depressive symptoms, irritability, sleep changes, and activity fluctuations require developmentally informed assessment, including a careful history of distinct episodes and alternative explanations. A child's or teenager's presentation should not be interpreted through adult symptom descriptions alone. Youth treatment choices also require specialized evidence and monitoring. NICE CG185 provides separate recommendations for children and young people.
During pregnancy and the postpartum period, depressive episodes, recurrence vulnerability, sleep loss, and medication risks require coordinated care with clinicians experienced in perinatal mental health. Medication decisions depend on maternal health, risks from untreated illness, reproductive safety, and the specific medicine. Some agents, particularly valproate, carry significant reproductive dangers. Changes to ongoing treatment should be planned with clinicians rather than made independently. NICE directs readers to specialized antenatal and postnatal guidance.
In older adults, physical illness, altered sleep, cognitive complaints, multiple prescriptions, and medication interactions complicate assessment. New depressive symptoms warrant evaluation of medical contributors and mental-health history. Treatment remains possible but requires individualized monitoring. NICE CG185 includes considerations for older people with bipolar disorder.
Common Misconceptions
Bipolar depression cannot be diagnosed from occasional mood swings, and a particularly deep episode of sadness does not prove an underlying bipolar disorder. The diagnosis depends on the broader clinical course, especially mania or hypomania. Bipolar II is not inherently a minor illness: prolonged depression may create major impairment. Mixed features do not require simultaneous happiness and sadness; they involve specified symptoms of opposing polarity evaluated clinically. A negative questionnaire cannot settle a complex history. These distinctions follow the episode-based frameworks in NIMH and NICE.
Recovery is also more complex than a single good day or a favorable response to one medication. Treatment must assess symptoms, functioning, adverse effects, mood switching, and long-term stability. Improvement can be substantial, and follow-up remains valuable because course and relapse risk vary. NICE's longitudinal management recommendations address these priorities.
Frequently Asked Questions
What does bipolar depression feel like?
People may experience hopelessness, numbness, loss of pleasure, exhaustion, changes in sleep and appetite, difficulty thinking, physical slowing or agitation, and reduced ability to work or connect with others. The presentation varies. None of these subjective experiences on its own distinguishes bipolar depression from other causes of depression; clinical history is essential. NIMH outlines the principal features.
Can someone have bipolar depression without ever having mania?
Bipolar II disorder includes major depression and hypomania without full mania. Bipolar I requires a history of mania. If a person has only had depression and has never had mania or hypomania, depressive symptoms alone cannot establish a bipolar I or II diagnosis. Sometimes earlier hypomania is discovered only after detailed questioning. NIMH explains these subtypes.
Is bipolar depression the same as bipolar II disorder?
No. Bipolar depression refers to a depressive episode occurring in bipolar illness; bipolar II is a diagnosis characterized by hypomania and major depression, without mania. Bipolar I can also involve severe depressive episodes. The type is determined by the lifetime episode history. NIMH provides the classification.
Can bipolar depression last for months?
Yes. Two weeks is the minimum duration for a major depressive episode, not an upper limit. Symptoms may persist longer or continue below full episode thresholds between recurrences. Prospective longitudinal findings in bipolar I and bipolar II demonstrate substantial depressive burden, although they cannot predict one person's course.
Is sleeping too much a sign of bipolar depression?
Hypersomnia can occur during bipolar depressive episodes, but it is also found in other depressive and medical conditions. Its presence warrants contextual assessment, not a diagnostic conclusion. Ask how it relates to energy, functioning, and any periods of unusually reduced sleep need. NIMH describes changes in sleep across mood states.
Can someone feel depressed and energized at the same time?
Yes. Some depressive episodes include mixed features involving activation or other symptoms associated with mania or hypomania. Anxiety, insomnia, medication effects, and other problems may also cause agitation or increased activity. New marked activation alongside depression, particularly with worsening judgment or suicidal thoughts, requires prompt assessment. NICE includes relevant monitoring and safety guidance.
Can an antidepressant worsen bipolar depression?
Antidepressant-associated switching into mania or hypomania and other mood destabilization are recognized clinical concerns. Monotherapy is generally not recommended for bipolar I depression. The recommendations for bipolar II and combinations of medicines depend on the patient's history and clinical situation. People with concerns about adverse effects should contact their prescriber and avoid abrupt medication changes. CANMAT/ISBD (2023) discusses the evidence.
Can a bipolar depression screening test make the diagnosis?
No. Symptom questionnaires and bipolar screening tools can prompt evaluation or monitor severity, but they cannot independently confirm bipolar I, bipolar II, or a depressive episode. Clinical diagnosis requires an assessment of episode criteria, functioning, treatment and substance effects, alternative explanations, and longitudinal history. See VA/DoD (2023).
Can people recover from bipolar depression?
Many people experience meaningful symptom relief and improved functioning with individualized care. Recovery may involve treating the depressive phase, planning for recurrence, physical-health monitoring, psychotherapy, and support for everyday goals. The pattern of future episodes remains individual. NIMH and NICE describe long-term care.
When should someone seek professional or emergency help?
Assessment is warranted when depression persists, recurs, or interferes with daily functioning, particularly if a history of unusual energy or sleep changes suggests bipolar illness. Seek emergency care for suicidal intent, severe psychosis, extreme behavioral disorganization, inability to maintain basic safety, or rapidly escalating mania. Arrange timely professional care for less immediate but significant symptoms. NICE CG185 provides a clinical approach to risk.
Related Articles
OCD and Bipolar Disorder: What Is the Connection? Comorbidity, Diagnosis, Medication, and Treatment — A separate clinical discussion of obsessive-compulsive symptoms, bipolar episodes, coexisting illness, and treatment considerations.
OCD vs Bipolar Disorder: What Is the Difference? Obsessions, Mood Episodes, Repetition, and Insight — A comparison of obsessions and compulsions with bipolar mood episodes, including the significance of timing and insight.
References
Forty, L., Smith, D., Jones, L., et al. (2008). Clinical differences between bipolar and unipolar depression. The British Journal of Psychiatry, 192(5), 388–389. https://doi.org/10.1192/bjp.bp.107.045294.
Judd, L. L., Akiskal, H. S., Schettler, P. J., et al. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59(6), 530–537. https://doi.org/10.1001/archpsyc.59.6.530.
Judd, L. L., Akiskal, H. S., Schettler, P. J., et al. (2003). A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry, 60(3), 261–269. https://doi.org/10.1001/archpsyc.60.3.261.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009.
Miklowitz, D. J., Efthimiou, O., Furukawa, T. A., et al. (2021). Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiatry, 78(2), 141–150. https://doi.org/10.1001/jamapsychiatry.2020.2993.
National Institute for Health and Care Excellence. (2014; updated 2025). Bipolar disorder: Assessment and management (CG185). https://www.nice.org.uk/guidance/cg185/chapter/Recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. https://www.nimh.nih.gov/health/publications/bipolar-disorder.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/bd/.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263.